Bausch Health Companies Aktie - BVF

Bausch Health Companies Inc (BVF) Aktie

Professionelle Tools für Privatanleger.

Premium

Current Price

4,28

( -0,28% )

Gebot

4,20

Fragen

4,358

Volumen

16.610

4,05 Tagesbereich 4,304

0,00 52-Wochen-Bereich 0,00

Handelsende

4,292

Handelsbeginn

4,304

Letzte Trade

535

4.248

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that Mark K. Oki has been...

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

* Biovail Shareholders Asked to Support Two Independent Directors That are Not Tied to Management or to Eugene Melnyk * TORONTO, May 11...

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) today announced that it has entered into an...

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC Investigation of...

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Nov. 21 /PRNewswire/ -- The...

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and Financial...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

BVF - Frequently Asked Questions (FAQ)

What is the current Bausch Health Companies Inc share price?

The current share price of Bausch Health Companies Inc is 4,28 €

What is the 1 year trading range for Bausch Health Companies Inc share price?

Bausch Health Companies Inc has traded in the range of 0,00 € to 0,00 € during the past year

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Bausch Health Companies Inc (BVF)

Bausch Health Companies Inc (BVF) Aktie

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

BVF Neueste Nachrichten

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

/ C O R R E C T I O N -- Scott + Scott, LLC /

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Biovail Reports Third Quarter 2003 Financial Results - Correction

BVF - Frequently Asked Questions (FAQ)

BVF Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Bausch Health Companies Inc (BVF)

Bausch Health Companies Inc (BVF) Aktie

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

BVF Neueste Nachrichten

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

/ C O R R E C T I O N -- Scott + Scott, LLC /

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Biovail Reports Third Quarter 2003 Financial Results - Correction

BVF - Frequently Asked Questions (FAQ)

BVF Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE